Bora Pharmaceuticals USA Inc. announced that it will receive $57,000,000 in an equity round of funding on May 14, 2024. The transaction include the participation from returning investor, Bora Pharmaceuticals Co., LTD., hold 100% stake in the company. The transaction has been approved by the board of directors of the company.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
772 TWD | -1.03% |
|
-0.13% | +20.81% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.81% | 2.4B | |
+51.82% | 797B | |
+40.01% | 628B | |
+16.95% | 323B | |
+9.49% | 300B | |
+16.66% | 244B | |
+0.45% | 223B | |
+9.43% | 214B | |
+5.30% | 163B | |
-6.29% | 153B |
- Stock Market
- Equities
- 6472 Stock
- News Bora Pharmaceuticals Co., LTD.
- Bora Pharmaceuticals USA Inc. announced that it expects to receive $57 million in funding from Bora Pharmaceuticals Co., LTD.